RBI Rate Cut Diluted Its Previous Policy Framework Nomura Suggests Kezar Life Sciences Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports No Revenue Novartis Raises FullYear Sales and Profit Guidance Signaling Strong Operational Momentum Kyntra Bio Inc Q1 2026 Earnings EPS Miss Amid Ongoing PreRevenue Development Phase STAA Q1 2026 Earnings Significant EPS Surprise Driven by Strong Operational Leverage ADMA Q1 2026 Earnings Narrow EPS Miss Overshadowed by Strong Stock Gains Oruka Therapeutics Inc ORKA Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction CCLD Q1 2026 Earnings EPS Misses Estimates as Company Invests for Growth MNR Q1 2026 Earnings Significant EPS Miss Stock Holds Steady XIFR Q1 2026 Earnings Huge EPS Beat Drives 532 Stock Surge LPX Q1 2026 Earnings Strong EPS Surprise of 218 Exceeds Expectations